Skip to main content

Table 5 Kawasaki features and associated symptoms of Kawasaki disease shock syndrome, and Septic shock group

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS(n=13) SS (n=29) P value
Kawasaki features
 Conjunctival injection 92.3% (12/13) 10.3% (3/29) 0.000
 Oropharyngeal changes 84.6% (11/13) 17.2% (5/29) 0.000
 Polymorphous rash 76.9% (10/13) 69.0% 1 (20/29) 0.722
 Cervical lymphadenopathy 69.2% (9/13) 3.4%(1/29) 0.000
 Extremity changes 92.3% (12/13) 34.5% (10/29) 0.001
Associated symptoms
 Gastrointestinal symptoms 84.6% (11/13) 82.8% (24/29) 1.000
 Respiratory symptoms 76.9% (10/13) 41.4% (12/29) 0.033
 Neurologic symptoms 23.1% (3/13) 51.7% (15/29) 0.083
 Systemic pain 53.8% (7/13) 37.9% (11/29) 0.335
Pleural effusion 76.9% (10/13) 41.4% (12/29) 0.033
Organ damage 92.3% (12/13) 82.8% (24/29) 0.647
  1. KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome